Extended dosing intervals for Pfizer or Moderna vaccines may be considered for certain individuals ages 12 to 64 years, not only to lower the risk of vaccine-associated myocarditis, but to potentially improve vaccine effectiveness, CDC staff said on Thursday.
According to the agency's new interim guidance, young people ages 12 to 39 may especially benefit from a second mRNA dose 8 weeks after their first dose.
Problem, Solution, SitRep, or ?:
Recent Comments